Portugal
12 Vaccines Approved for Use in Portugal
Protein Subunit
RNA
RNA
Pfizer/BioNTech
Comirnaty
Approved in 149 countries
100 trials in 31 countries
Approval Source: ema.europa.eu
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Ad26.COV2.S
Approved in 111 countries
23 trials in 23 countries
Approval Source: ema.europa.eu
Non Replicating Viral Vector
Oxford/AstraZeneca
Vaxzevria
Approved in 149 countries
73 trials in 34 countries
Approval Source: ema.europa.eu
RNA
Moderna
Spikevax Bivalent Original/Omicron BA.1
Approved in 38 countries
5 trials in 4 countries
Approval Source: ema.europa.eu
RNA
Pfizer/BioNTech
Comirnaty Bivalent Original/Omicron BA.1
Approved in 35 countries
3 trials in 5 countries
Approval Source: ema.europa.eu
RNA
Pfizer/BioNTech
Comirnaty Bivalent Original/Omicron BA.4/BA.5
Approved in 33 countries
4 trials in 1 country
Approval Source: ema.europa.eu
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Jcovden
Approved in 113 countries
26 trials in 25 countries
Approval Source: ema.europa.eu
Inactivated
RNA
Moderna
Spikevax Bivalent Original/Omicron BA.4/BA.5
Approved in 33 countries
2 trials in 1 country
Approval Source: ema.europa.eu
Protein Subunit
Sanofi/GSK
VidPrevtyn Beta
Approved in 30 countries
3 trials in 2 countries
Approval Source: ema.europa.eu
1 in Clinical Trials in Portugal
Protein Subunit
Laboratorios Hipra SA
COVID-19 vaccine HIPRA
10 trials in 4 countries